Elbasvir/grazoprevir, sold under the brand name Zepatier, is a fixed-dose combination for the treatment of hepatitis C, containing elbasvir (an inhibitor
with the NS3/4A protease inhibitor grazoprevir under the trade name Zepatier, either with or without ribavirin. Elbasvir is a highly potent and selective
NS5A replication complex inhibitor elbasvir under the trade name Zepatier, either with or without ribavirin. Grazoprevir is a second generation hepatitis
12 weeks of elbasvir/grazoprevir, ledipasvir/sofosbuvir, or sofosbuvir/velpatasvir. An alternative treatment regimen of elbasvir/grazoprevir with weight-based